Immatics N.V. Ordinary Shares
Symbol: IMTX (NASDAQ)
6.70
▲ (1.36%) 0.090
Company Description:
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
Key Stats
- Today's Open: $6.62
- Today's High: $6.71
- Today's Low: $6.476
- Today's Volume: 1.37M
- Yesterday Close: $6.61
- Yesterday High: $6.76
- Yesterday Low: $6.18
- Yesterday Volume: 505.14K
- Last Min Volume: 14
- Last Min High: $6.7
- Last Min Low: $6.7
- Last Min VWAP: $6.7
Company Profile
- Name: Immatics N.V. Ordinary Shares
- Website: https://www.immatics.com
- Listed Date: 2020-07-02
- Location: ,
- Market Status: Active
- CIK Number: 0001809196
- SIC Code:
- SIC description:
- Market Cap: $814.45M
- Round Lot: 100
- Outstanding Shares: 121.56M
- Asset Type: CS
RECENT FILINGS FOR IMTX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-13 | SCHEDULE 13G/A | View |
| 2025-08-13 | 6-K | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-07-02 | S-8 | View |
| 2025-07-01 | 25-NSE | View |
| 2025-06-18 | 6-K | View |
| 2025-06-02 | 6-K | View |
| 2025-06-02 | 6-K | View |
| 2025-05-13 | 6-K | View |
| 2025-05-12 | SCHEDULE 13G/A | View |
| 2025-05-02 | SCHEDULE 13G/A | View |
| 2025-04-03 | EFFECT | View |
| 2025-04-01 | CORRESP | View |
| 2025-04-01 | UPLOAD | View |
| 2025-03-27 | F-3 | View |
| 2025-03-27 | 6-K | View |
| 2025-03-27 | 20-F | View |
| 2025-03-07 | SCHEDULE 13G/A | View |
Latest News on IMTX